Boskalis Annual Report 2020
84 84
CONSOLIDATED STATEMENT OF CASH FLOWS
2019
2020
Note
(in thousands of EUR)
CASH FLOWS FROM OPERATING ACTIVITIES Net Group profit / loss (-)
74,899
- 96,679
[10/15/16/ 27.1]
Depreciation, amortization and impairment charges
265,115 340,014
421,962 325,283
Cash flow
Adjustments for: Finance income and expenses
15,681 20,141 - 6,756 - 40,146 - 48,013 33,683 - 3,477 - 31,368 - 31,667 144,336 - 25,590
14,888 26,216 - 8,546
[11] [12]
Income tax expenses Results from disposals
[7]
Reversal of impairments evidenced by a sale transaction Results from divestments and acquisitions Movement in provisions and employee benefits
- -
[10]
- 27,121 11,356 178,164 77,638 107,918
Movement in inventories
Movement in trade and other receivables Movement in trade and other payables Movement unbilled and deferred revenue
Share in result of joint ventures and associates, including share in impairment charges
7,877
[17]
Gain on acquisitions
-
- 7,569 706,104
[5]
Cash generated from operating activities
366,838
Dividends received Interest received
10,191
20,446
[17] [11]
995
369
Interest paid
- 12,625 - 37,293 328,106
- 11,970 - 16,893 698,056
Income tax paid
ANNUAL REPORT 2020 – BOSKALIS FINANCIAL STATEMENTS 2020 A NUAL REPORT 2020 -- BOSKALIS FI ANCIAL STATEMENTS 2 20 Net cash from operating activities CASH FLOWS FROM FINANCING ACTIVITIES Proceeds from interest-bearing borrowings Repayment of interest-bearing borrowings Purchase of own shares Payment of lease liabilities Dividend paid to shareholders Currency translation differences
CASH FLOWS FROM INVESTING ACTIVITIES Purchases of property, plant and equipment, excluding capitalized borrowing costs
- 247,590 26,704 - 23,250 - 75,409 291,464
- 225,624 17,355 - 43,183
[16]
Proceeds from disposals of property, plant and equipment Investment in business combinations, net of cash acquired Investment in and issued loans to joint ventures and / or associates
[5]
- -
[17/18]
Disposal of (a part of) group companies, net of cash disposed, and joint ventures Repayment of loans or share premium by joint ventures and / or associates
[5]
280
1,192
[17/18]
Net cash used from / (in) investing activities
- 27,801
- 250,260
-
508,411 - 453,648 - 5,435 - 29,403 - 27,977
[24] [24] [24] [23]
- 100,245
Transaction costs paid related to new finance agreement
-
- 46,820 - 23,818 - 66,999 - 237,882
[27.2]
-
[23]
Net cash used from / (in) financing activities
- 8,052
62,423
439,744
NET INCREASE / (DECREASE) IN CASH AND CASH EQUIVALENTS
Net cash and cash equivalents as at 1 January
307,877
369,799
[22]
Net increase / (decrease) in cash and cash equivalents
62,423
439,744
- 501
5,449
61,922 369,799
445,193 814,992
MOVEMENT IN NET CASH AND CASH EQUIVALENTS
[22]
NET CASH AND CASH EQUIVALENTS AS AT 31 DECEMBER
The notes on pages 87 to 141 are an integral part of these Consolidated Financial Statements.
Made with FlippingBook Publishing Software